56919
Perfluoroperhydrophenanthrene
Selectophore™
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
About This Item
Formule empirique (notation de Hill):
C14F24
Numéro CAS:
Poids moléculaire :
624.11
Numéro Beilstein :
2514226
Numéro MDL:
Code UNSPSC :
26111700
ID de substance PubChem :
Nomenclature NACRES :
NB.61
Produits recommandés
Qualité
for ion-selective electrodes
Niveau de qualité
Description
solvent for preparation of membranes
Gamme de produits
Selectophore™
Point d'ébullition
212-218 °C
Densité
2.03 g/mL at 20 °C
Chaîne SMILES
FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(C1(F)F)C(F)(F)C(F)(F)C3(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C23F
InChI
1S/C14F24/c15-1-2(16)4(18,10(29,30)14(37,38)12(33,34)6(2,21)22)8(25,26)7(23,24)3(1,17)9(27,28)13(35,36)11(31,32)5(1,19)20
Clé InChI
QKENRHXGDUPTEM-UHFFFAOYSA-N
Catégories apparentées
Description générale
Visit our Sensor Applications portal to learn more.
Application
Perfluoroperhydrophenanthrene finds application as an intraoperative and postoperative surgical adjunct tool, during retinal operations and study.
Solvent for fluorous liquid phase in ion-selective electrodes
Informations légales
Selectophore is a trademark of Merck KGaA, Darmstadt, Germany
Code de la classe de stockage
10 - Combustible liquids
Classe de danger pour l'eau (WGK)
WGK 3
Point d'éclair (°F)
Not applicable
Point d'éclair (°C)
Not applicable
Choose from one of the most recent versions:
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Les clients ont également consulté
H Wafapoor et al.
International ophthalmology, 22(2), 89-96 (1999-09-03)
To evaluate the utility and efficacy of perfluoroperhydrophenanthrene in the management of retinal detachments secondary to severe proliferative diabetic retinopathy. Forty consecutive patients with proliferative diabetic retinopathy and retinal detachments were entered into the study at nine participating clinical centers.
Ulrike Stolba et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 242(11), 931-936 (2004-07-20)
To evaluate the histological changes in the retina after experimental vitreous substitution with various amounts of perfluorophenanthrene (PFPH). Thirty-two rabbit eyes were mechanically vitrectomized and filled up with 0.8 cc or 0.2 cc highly purified PFPH. The substance remained for
U Stolba et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 237(6), 501-507 (1999-06-24)
We evaluated biomicroscopic and histological effects on the anterior segment in the rabbit eye after temporary aqueous substitution with various amounts (0.2 cc and 0.025 cc) of perfluorodecaline (PFD) and perfluorophenanthrene (PFP). A quantity of 0.2 cc of the two
I U Scott et al.
Ophthalmology, 107(5), 860-865 (2000-05-16)
To compare rates of perfluorocarbon liquid (PFCL) intraocular retention, anatomic and visual acuity outcomes, and complications associated with intraoperative perfluoro-n-octane (Perfluoron) versus perfluoroperhydrophenanthrene (Vitreon) in retinal detachment repair. Retrospective noncomparative consecutive case series. Records of consecutive patients who underwent retinal
A Loewenstein et al.
Ophthalmology, 107(6), 1078-1082 (2000-06-17)
To compare two perfluorocarbon liquids, perfluoroperhydrophenanthrene (Vitreon) and perfluoro-n-octane (PFO), regarding (1) ease of removal at the time of surgery and (2) efficacy and safety. Retrospective, nonrandomized, comparative trial. Two hundred sixty-four patients. All medical records of patients who participated
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique